06:53 AM EDT, 04/30/2026 (MT Newswires) -- Merck (MRK) reported a Q1 adjusted loss Thursday of $1.28 per share, swinging from earnings of $2.22 a year earlier.

Analysts polled by FactSet expected a loss of $1.47.

Sales for the quarter were $16.29 billion, compared with $15.53 billion a year earlier.

Analysts polled by FactSet expected $15.85 billion.

For 2026, the company now expects adjusted EPS of $5.04 to $5.16, compared with its prior outlook range of $5 to $5.15. Analysts are looking for $5.10.

Merck said it now projects full-year sales at $65.8 billion to $67 billion versus its previous guidance range of $65.5 billion to $67 billion. Analysts are looking for $66.58 billion.

The company's shares were up 5.5% in premarket activity.